Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.79 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.79 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.79 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.79 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.79 |
| ▸ | SLC18A2 | Q05940 | 8/20 | 0.66 |
| ▸ | HTR2A | P28223 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29929867 | 1.00 | HTR1A (0.79) | HTR1ATBXA2RPTGS1OPRM1KCNH2 | |
| Hydrochloric Acid SCHEMBL28855272 | 0.99 | HTR1A (0.77) | HTR1ATBXA2RPTGS1OPRM1KCNH2 | |
| Hydrochloric Acid SCHEMBL29930283 | 0.99 | HTR1A (0.77) | HTR1ATBXA2RPTGS1OPRM1KCNH2 | |
| SCHEMBL23119609 | 0.90 | HTR1A (0.86) | HTR1ATBXA2RPTGS1OPRM1KCNH2 | |
| SCHEMBL22611890 | 0.90 | HTR1A (0.86) | HTR1ATBXA2RPTGS1OPRM1KCNH2 | |
| SCHEMBL29608636 | 0.90 | HTR1A (0.86) | HTR1ATBXA2RPTGS1OPRM1KCNH2 | |
| SCHEMBL20278159 | 0.90 | HTR1A (0.83) | HTR1ATBXA2RPTGS1OPRM1KCNH2 | |
| SCHEMBL22186209 | 0.90 | HTR1A (0.83) | HTR1ATBXA2RPTGS1OPRM1KCNH2 | |
| SCHEMBL20411762 | 0.90 | HTR1A (0.83) | HTR1ATBXA2RPTGS1OPRM1KCNH2 | |
| SCHEMBL19024415 | 0.90 | HTR1A (0.86) | HTR1ATBXA2RPTGS1OPRM1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108473489-B | VALBENAZINE salts and polymorphs thereof | 纽罗克里生物科学有限公司 | 2022-09-02 | — | — | CN | disclosed |